Contact information for researchers and applicants

Vrouw met headset

Scientific Review and Grants Administration

If you have any questions, please contact our Scientific Review and Grants Administration (team Bestedingen). They are happy to help you with the administrational procedures regarding research project proposals. They can also refer you to one of our Programme Coordinators.

T: +31 20 - 570 04 50
bestedingen@kwf.nl 

Programme Coordinator Team

Dr. Laurien Hoefnagel - Secretary Review Board Development & Implementation / Programme coordinator Biomarkers

Responsible for supporting the review board Development & Implementation in the review process and monitoring the process and procedures for reviewing project proposals.

Biomarkers are characteristics that are objectively measured and evaluated as an indicator for cancer risk, the presence of a specific cancer or recurrent cancer, the stage or severity of a specific cancer, and how well patients respond to therapy.

Dr. Miranda Wijdenes - Programme coordinator Biomarkers

Biomarkers are characteristics that are objectively measured and evaluated as an indicator for cancer risk, the presence of a specific cancer or recurrent cancer, the stage or severity of a specific cancer, and how well the patient responds to therapeutic intervention(s).

Dr. Marion Scharpfenecker - Programme coordinator Biomarkers

Biomarkers are characteristics that are objectively measured and evaluated as an indicator for cancer risk, the presence of a specific cancer or recurrent cancer, the stage or severity of a specific cancer, and how well the patient responds to therapeutic intervention(s).  

Dr. Sanne Kuijper - Programme coordinator NKI & Basic Research 

Scientific research aimed at obtaining insight into the origin and progression of cancer, its (psychosocial) effects, as well as basic principles of prevention and treatment of cancer and relevant technological developments. Basic research does not directly focus on the possible application of this knowledge.

Dr. Nora Liu - Programme coordinator Basic Research 

Scientific research aimed at obtaining insight into the origin and progression of cancer, its (psychosocial) effects, as well as basic principles of prevention and treatment of cancer and relevant technological developments. Basic research does not directly focus on the possible application of this knowledge.  

Dr. Bas Pouw - Programme coordinator Imaging

A type of test (i.e. CT, MRI, ultrasound) that makes detailed pictures of areas inside the body. Imaging tests use different forms of energy, such as x-rays (high-energy radiation), ultrasound (high-energy sound waves), radio waves, and radioactive substances. They may be used to help diagnose disease, plan treatment, or find out how well treatment is working.  

Drs. Maarten van den Ende - Programme coordinator Agents  

Drugs or biologicals used to prevent or inhibit the proliferation of cancerous cells. Examples of agents are small molecules, therapeutic enzymes and hormones.

Drs. Fleur Huijsman - Programme coordinator Lifestyle and Exposure 

The influence of behaviour or (unwanted) exposure to exogenous factors on the development, the recurrence, the aggravation, or the prevention of cancer, and/or the development, the aggravation, or the prevention of side effects from cancer (treatment). 

Dr. Willeke la Fontaine - Ros - Programme coordinator Immunotherapy

Immunotherapy is a cancer treatment that helps the patient’s own immune system to recognize and destroy cancer. Examples are monoclonal antibodies (drugs that counteract immune suppression or mark cancer cells for destruction), cytokines (small proteins that regulate immune responses) and therapeutic vaccines.

Dr. Sigrid Oomen - Programme coordinator Interventive Devices 

Treatment instruments to prevent or treat local-regional sites of cancer or precancerous lesions. The modalities may be delivered non-invasively (e.g. radiation therapy), minimally invasively (e.g.cryoablation, hyperthermia) or by open surgery (invasive).

Dr. Renée de Bruin - Programme coordinator Quality of Life 

Quality of life is among other things influenced by the psychological, social and societal impact of the disease. This compromises subjects as anxiety, depression, relational problems, return to work, the degree of independence and personal beliefs. Even when the disease can no longer be cured.

Dr. Jeroen Dudok- Secretary Review Board Exploration

Secretary of the scientific review board Exploration in which project proposals in the exploration track (basic research and credentialing) are reviewed. Responsible in this position for supporting the board in the review process and monitoring the process and procedures for reviewing project proposals. 

Drs. Eveline Noteboom - Programme coordinator Implementation

Research on methods to facilitate the implementation of concrete applications (with demonstrable added value compared to the current practice) into oncology policy and practice at national level. Implementation focuses on the actions of healthcare professionals and other stakeholders as a key variable in the sustainable implementation of evidence-based interventions.

Dr. Delphi Coppens - Programme coordinator Cell & Gene Therapy

Cell therapy is the transfer of living cells into a patient to treat cancer. It usually involves immune cells that have been modified to recognize and destroy cancer cells (e.g. dendritic cell vaccination or CAR T-cell therapy). Gene therapy is transfering genetic material into a patient and alterating the genetic code to treat cancer.

Dr. Jens van der Vaart - Programme coordinator Clinical trials (focus: immunotherapy)

Clinical trials are research studies performed in people to find out if new treatments are safe and effective. KWF supports researchers in conducting their trials and disseminating and implementing their results.

Dr. Linda Schoo - Programme Coordinator Quality of Care

Scientific studies aimed at providing the most appropriate care to all cancer patients in all regions through optimal availability of therapies and the correct use thereof. Patient-driven indicators and real world evidence are included in the shared decision making process where possible. The results contribute to the best fitted treatment strategy for each individual patient, to providing (health) care providers with the most recent insights, and to transparency about the quality of the care offered.

Drs. Mai Tran - Programme coordinator Infrastructure

Infrastructural initiatives provide services, resources and networks to support cancer research. These initiatives enable the research community to address specific research questions and thereby help accelerate and/or optimise the exploitation of results to the patients and public.